Results 281 to 290 of about 5,628,828 (349)

Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure. [PDF]

Front Oncol
Kort J, Rivera A, Senigarapu S, Driscoll JJ.   +3 more
europepmc   +1 more source

Extensive extramedullary haematopoiesis in a patient with non‐transfusion‐dependent beta‐thalassaemia

British Journal of Haematology, EarlyView.
Laura Distelmaier, Wolfgang G. Kunz, Sebastian Theurich   +2 more
wiley   +1 more source

Distinct patient, tumour and chimeric antigen receptor T‐cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma

British Journal of Haematology, EarlyView.
Translational analyses from the KarMMa trial (NCT03361748) highlight that baseline tumour burden, immune environment and chimeric antigen receptor (CAR) T‐cell dynamics influence both the initiation and durability of response to idecabtagene vicleucel (ide‐cel) in relapsed and refractory multiple myeloma.
Nathan Martin, Ethan Thompson, Nicholas Stong, Yang Xu, Olivia Finney, Julie Rytlewski, Erin Flynt, Jessica Marfo, Dante B. Descalzi‐Montoya, Irene Manrique, Bruno Paiva, Nikhil Munshi, Timothy B. Campbell, Shari M. Kaiser   +13 more
wiley   +1 more source

Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma. [PDF]

Blood Cancer J
Golmohammadi M, Raza S, Albayyadhi M, Sholehrasa H, Khouri J, Williams L, Hansen DK, Moradi A, Xu X, Albliwi M, Ali AH, Dima D, Anwer F, Paul B, Jaberi-Douraki M.   +14 more
europepmc   +1 more source

Correction to "The potential link between Covid-19 and multiple myeloma: A new saga". [PDF]

Immun Inflamm Dis
europepmc   +1 more source

Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement. [PDF]

Blood Cancer J
Steinhardt MJ, Schaefers C, Leypoldt LB, Blau IW, Harzer M, Zhou X, Riedhammer C, Kamili A, Kosch R, Topp LS, Molwitz I, Gross-Fengels NO, Melzer YF, Artzenroth J, Al-Bazaz M, Alsdorf W, Topp MS, Duell J, Mersi J, Waldschmidt J, Bokemeyer C, Einsele H, Kortüm KM, Weisel K, Rasche L.   +24 more
europepmc   +1 more source

Regulatory role of the METTL3/MALAT1 axis in multiple myeloma progression. [PDF]

J Bone Oncol
Lu X, Li Y, Li R, Zhang J, Peng J, Zhang Y.   +5 more
europepmc   +1 more source

Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma. [PDF]

Blood Cancer J
Messiou C, Porta N, Koh DM, Riddell A, Downey K, Croft J, Conneely L, Hopkinson G, Dragan A, Brown T, Stern S, Cheung B, Kyriakou C, Kaczmarek P, Boyd K, Pawlyn C, Winfield J, Kaiser MF.   +17 more
europepmc   +1 more source